Inventor
LI HUI-YIN
US34 patents
⚠️ This page may combine multiple inventors who share the name “LI HUI-YIN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
INCYTE CORP
7 patentsUS8829013B1Sep 9, 2014
Salts of the Janus kinase inhibitor (R)-3-(4-(7H-pyrrolo[2,3-D]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile
INCYTE CORP91 citations99
US8822481B1Sep 2, 2014
Salts of the janus kinase inhibitor (R)-3-(4-(7H-pyrrolo[2,3-d] pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile
INCYTE CORP89 citations99
US8722693B2May 13, 2014
Salts of the Janus kinase inhibitor (R)-3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile
INCYTE CORP143 citations99
US9464088B2Oct 11, 2016
Piperidin-4-yl azetidine derivatives as JAK1 inhibitors
INCYTE CORP57 citations98
US9376439B2Jun 28, 2016
Salts of the janus kinase inhibitor (R)-3(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile
INCYTE CORP62 citations98
US10125150B2Nov 13, 2018
Crystalline forms of a PI3K inhibitor
INCYTE CORP15 citations93
US9988401B2Jun 5, 2018
Crystalline forms of a PI3K inhibitor
INCYTE CORP14 citations93
BRISTOL MYERS SQUIBB PHARMA CO
7 patentsUS6541639B2Apr 1, 2003
Efficient ligand-mediated Ullmann coupling of anilines and azoles
BRISTOL MYERS SQUIBB PHARMA CO92 citations95
US6465656B2Oct 15, 2002
Synthesis of 1,3,5-trisubstituted pyrazoles
BRISTOL MYERS SQUIBB PHARMA CO12 citations73
US6329527B1Dec 11, 2001
Synthesis of 1,3,5-trisubstituted pyrazoles
BRISTOL MYERS SQUIBB PHARMA CO12 citations73
US6667332B2Dec 23, 2003
Efficient process for the preparation of a factor Xa inhibitor
BRISTOL MYERS SQUIBB PHARMA CO11 citations72
US6747158B2Jun 8, 2004
Efficient process for the preparation of a factor Xa inhibitor
BRISTOL MYERS SQUIBB PHARMA CO4 citations61
US6610858B2Aug 26, 2003
Efficient method for the conversion of nitriles to amidines
BRISTOL MYERS SQUIBB PHARMA CO0 citations52
US6399784B2Jun 4, 2002
Efficient method for the conversion of nitriles to amidines
BRISTOL MYERS SQUIBB PHARMA CO0 citations52
DU PONT PHARM CO
5 patentsUS5856525AJan 5, 1999
Asymmetric R and S warfarin and its analogs
DU PONT PHARM CO24 citations90
US5932749AAug 3, 1999
Asymmetric synthesis of R-α-propyl-piperonyl amine and its analogs
DU PONT PHARM CO33 citations89
US6245914B1Jun 12, 2001
Efficient method for the conversion of nitriles to amidines and species thereof
DU PONT PHARM CO2 citations63
US6194569B1Feb 27, 2001
Efficient process for the preparation of [S-(R,S)]-N-[1,3-benzodioxol-5-yl)butyl]-3,3-diethyl-2[4-[4-methyl-1-piperazinyl)carbonyl]phenoxy]-4-oxo-1-azetidine carboxamide, a human leukocyte elastase inhibitor
DU PONT PHARM CO3 citations59
US5962693AOct 5, 1999
Efficient method for the conversion of nitriles to amidines
DU PONT PHARM CO0 citations52
INCYTE HOLDINGS CORP
3 patentsUS10016429B2Jul 10, 2018
Salts of the janus kinase inhibitor (R)-3-(4-(7H-pyrrolo[2,3-D]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile
INCYTE HOLDINGS CORP10 citations92
US11213528B2Jan 4, 2022
Salts of the janus kinase inhibitor (R)-3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile
INCYTE HOLDINGS CORP5 citations84
US10610530B2Apr 7, 2020
Salts of the Janus kinase inhibitor (R)-3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile
INCYTE HOLDINGS CORP8 citations84